Background: Botulinum toxin (BT) is a common treatment intervention for the management of
spasticity in children with Cerebral Palsy (CP). There are no national or internationally …

AbobotulinumtoxinA (ABO) has been used for the treatment of spasticity in children with
cerebral palsy (CP). Its use requires careful administration, regarding dosing, selection of …

ABSTRACT Introduction: The Patient Dignity Inventory of Chochinov et al.(2008), was
projected to measure sources of dignity related suffering among patients approaching the …

A Encefalopatia Não Progressiva Crônica da Infância (ENPCI), também conhecida como
Paralisia Cerebral (PC), pode ser classificada nas formas espástica, discinética, atáxica ou …

Background: Spasticity is the most common symptom among individuals with Cerebral Palsy
(CP). Spasticity is often presented as stiff limbs often resulting in pain. Currently, clinicians …

Appropriate bimanual coordination is essential for many tasks in daily life. Children with
unilateral cerebral palsy (uCP) however struggle with the execution of such tasks. Extensive …

Children with cerebral palsy (CP) are at risk of secondary changes, such as bone
deformation. Physical activity is important to reduce these changes and to improve physical …

[ES] Objetivo: Reunir las principales evidencias científicas para determinar la efectividad de
la hipoterapia en personas con parálisis cerebral. Material y métodos: Se realizó una …

Introduction: The functional limitations associated with Cerebral Palsy (CP) and inactivity are
directly related to the deficit in postural control, namely the Early Postural Adjustments …